KRAS and pancreatic intraductal papillary-mucinous neoplasm: Given the relatively low sensitivity but high specificity of KRAS and GNAS detection in cfDNA, our primary conclusion is that the absence of these mutations supports a conservative surveillance approach, particularly for branch duct IPMN lacking worrisome features.